Stocks
Health Care
cstl
Castle Biosciences
NASDAQ: CSTL
-0.21 (-0.84%)
24.84
USD
At close at Apr 03, 20:40 UTC
Income Statement
Revenue
332.07M
Gross Profit
271.86M
Operating Income
8.67M
Pretax Income
-29.51M
Net Income
18.25M
EBITDA
38.14M
EBIT
22.14M
Earnings Per Share
0.6599999999999999
Balance Sheet
Cash & Cash Equivalents
95.80M
Total Debt
25.83M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
430.81M
Book Value Per Share
15.55
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.